| Product NDC: | 55154-9728 |
| Proprietary Name: | Renvela |
| Non Proprietary Name: | SEVELAMER CARBONATE |
| Active Ingredient(s): | 800 mg/1 & nbsp; SEVELAMER CARBONATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-9728 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022127 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090812 |
| Package NDC: | 55154-9728-4 |
| Package Description: | 270 POUCH in 1 CARTON (55154-9728-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-9728-6) |
| NDC Code | 55154-9728-4 |
| Proprietary Name | Renvela |
| Package Description | 270 POUCH in 1 CARTON (55154-9728-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-9728-6) |
| Product NDC | 55154-9728 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SEVELAMER CARBONATE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090812 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | SEVELAMER CARBONATE |
| Strength Number | 800 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |